Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference29 articles.
1. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients;Habel;Breast Cancer Res,2006
2. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials;Fisher;Lancet,2004
3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,2005
4. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early;Goldhirsch;Breast Cancer,2009
5. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas;Bukholm;Int J Cancer,2001
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Application of CCNB1 and ASPM in the Treatment of Diabetes Foot Ulcer Based on High-Throughput Transcriptome;Advances in Clinical Medicine;2024
2. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor;BMC Medical Genomics;2023-08-17
3. Cyclin B1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms Tumour;2023-03-20
4. Cell Cycle Dysregulation in Breast Cancer;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023
5. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development;Breast Cancer Research and Treatment;2022-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3